CA973475A - Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine - Google Patents

Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine

Info

Publication number
CA973475A
CA973475A CA120,678A CA120678A CA973475A CA 973475 A CA973475 A CA 973475A CA 120678 A CA120678 A CA 120678A CA 973475 A CA973475 A CA 973475A
Authority
CA
Canada
Prior art keywords
marek
culture
preparation
production
herpes virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA120,678A
Other versions
CA120678S (en
Inventor
William A.M. Gregg
Kenneth F. Lawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Connaught Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd
Priority to CA120,678A priority Critical patent/CA973475A/en
Priority to JP47077335A priority patent/JPS4828622A/ja
Application granted granted Critical
Publication of CA973475A publication Critical patent/CA973475A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA120,678A 1971-08-16 1971-08-16 Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine Expired CA973475A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA120,678A CA973475A (en) 1971-08-16 1971-08-16 Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine
JP47077335A JPS4828622A (en) 1971-08-16 1972-08-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA120,678A CA973475A (en) 1971-08-16 1971-08-16 Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine

Publications (1)

Publication Number Publication Date
CA973475A true CA973475A (en) 1975-08-26

Family

ID=4090612

Family Applications (1)

Application Number Title Priority Date Filing Date
CA120,678A Expired CA973475A (en) 1971-08-16 1971-08-16 Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine

Country Status (2)

Country Link
JP (1) JPS4828622A (en)
CA (1) CA973475A (en)

Also Published As

Publication number Publication date
JPS4828622A (en) 1973-04-16

Similar Documents

Publication Publication Date Title
EP0965345A3 (en) Use of acemannan
GB1517540A (en) Preparation for the treatment of infectious diseases method for the manufacture thereof and its use
GB1457382A (en) Process for preparing live varticella vaccines
DE3169848D1 (en) Herpes simplex type i fraction vaccine and process for its preparation
CA934295A (en) Vaccine for immunization of poultry against marek's disease
CA973475A (en) Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine
IE40221L (en) Influenza vaccines
DE2966648D1 (en) Vaccine against diseases caused by reo viruses, combined vaccine with newcastle disease virus, process for preparing them and reo virus strain used for their preparation
SU579309A1 (en) Method of preparing vaccine
IE39141L (en) Production of immunological material
CA1021261A (en) Herpes simplex type 2 virus vaccine and method of production and use
GB1358321A (en) Method od tissue cell culture
CA958641A (en) Equine strangles vaccine and method of preparing and using the same
ES8107024A1 (en) Feline infectious peritonitis vaccine and process for its preparation.
YU311779A (en) Process for preparing vaccines against the virus of early summer meningoencephalitis
ES8107300A1 (en) Herpes virus vaccine and its preparation.
IE40159B1 (en) Vaccine for marek's disease of poultry
AU2793971A (en) Marek's disease inactivated vaccine and process for preparing the same
GB1436323A (en) Cell and virus culture systems
AU486997B2 (en) Herpes simplex type 2 virus vaccine and method of production and use
CA960586A (en) Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same
AU1389088A (en) Novel alkyl alkanoates, process for their preparation and the use of aqueous emulsions of these esters in vaccines
AU505075B2 (en) Foetal canine lung cell strain and process for cultivation of viruses and vaccine therefrom
AU457758B2 (en) Infectious bovine rhinotracheitis virus vaccine and method of preparing and using thesame
CA883305A (en) Method of preparing phosphonic acid and derivatives thereof